ARHGEF9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.42029968183988E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.93678999999003E-05 |
Normal-vs-Stage2 |
3.06879999967258E-07 |
Normal-vs-Stage3 |
1.62900026801083E-10 |
Normal-vs-Stage4 |
1.65634173043827E-12 |
Stage1-vs-Stage2 |
3.064300E-02 |
Stage1-vs-Stage3 |
6.752600E-04 |
Stage1-vs-Stage4 |
1.30859999947219E-07 |
Stage2-vs-Stage3 |
7.383800E-01 |
Stage2-vs-Stage4 |
5.264000E-02 |
Stage3-vs-Stage4 |
4.649600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.88840054704542E-10 |
Normal-vs-AfricanAmerican |
3.58230000000459E-05 |
Normal-vs-Asian |
1.825350E-01 |
Caucasian-vs-AfricanAmerican |
6.839200E-01 |
Caucasian-vs-Asian |
3.403600E-01 |
AfricanAmerican-vs-Asian |
4.994000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.33471012020436E-12 |
Normal-vs-Female |
1.62696999999046E-05 |
Male-vs-Female |
4.607900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.373600E-04 |
Normal-vs-Age(41-60Yrs) |
1.5235999994978E-07 |
Normal-vs-Age(61-80Yrs) |
8.35319591274697E-11 |
Normal-vs-Age(81-100Yrs) |
5.046800E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.216200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.600200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.459800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.245990E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.082200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.959600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.314800E-01 |
Normal-vs-Grade 2 |
1.68343999999987E-05 |
Normal-vs-Grade 3 |
1.13609999186082E-09 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
1.157190E-01 |
Grade 1-vs-Grade 3 |
1.480080E-02 |
Grade 1-vs-Grade 4 |
1.41160000000085E-06 |
Grade 2-vs-Grade 3 |
1.344420E-02 |
Grade 2-vs-Grade 4 |
7.5356998419096E-10 |
Grade 3-vs-Grade 4 |
3.60569999999782E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.560750E-03 |
Normal-vs-ccB subtype |
1.87616588931405E-12 |
ccA subtype-vs-ccB subtype |
1.63470004199695E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.43919995313036E-09 |
Normal-vs-N1 |
8.975500009889E-09 |
N0-vs-N1 |
8.420200E-03 |
|
|